Design and Analysis of Phase II Trials in Oncology
March 31, 2011
IDDI organized a webinar on DESIGN AND ANALYSIS OF PHASE II TRIALS IN ONCOLOGY.
This webinar presented key concepts and current examples regarding the design and analysis of phase II trials in oncology. Aims, methods and limitations of phase II trials in oncology, including the important issues of study design, choice of endpoints, the need for randomization, and correct interpretation and decisions in the overall drug-development process.
TO ACCESS THE PRESENTATION OF THIS ON-DEMAND WEBINAR, PLEASE FILL OUT THE FORM BELOW